Banking & Finance

Mere weeks after making an unsolicited bid to buy Marlborough-based biotech firm Akoya Biosciences, the anonymous party has withdrawn its offer . 

Less than two weeks after the Senate moved to create a new prescription drug price cap system in Massachusetts, an industry official warned against legislative "leapfrog" that could complicate the most recent round of reforms.

Employees at Bowditch & Dewey, the Downtown Worcester Business Improvement District, and Quinsigamond Community College are moving forward as professionals.

The Boulevard Diner now stands as Central Massachusetts’ sole independently-owned diner operating with any kind of 24-hour model.

UMass Memorial Health has implemented a system-wide hiring pause on all non-clinical, non-patient-facing roles and shuttered two behavioral health clinics.

Massachusetts could face billions in lost federal revenue and heightened economic risk under the second Trump administration, a budget expert warned lawmakers Thursday, but he emphasized that a broad economic downturn could deal the hardest blow.

Nine Central Massachusetts nonprofits have received a total of nearly $1 million in grant funding for their efforts to provide small businesses with technical assistance training and access to financing.

The first five months of 2025 have been a wild ride for the economy. How has your outlook changed for the rest of the year?

Two months after its CFO abruptly resigned, Arch Therapeutics, a Framingham-based biotechnology company, has filed for Chapter 11 bankruptcy.

Hometown Financial Group will soon acquire CFSB Bancorp, forming a nearly $6.9-billion entity.